Cargando…
Ursodeoxycholic acid after common bile duct stones removal for prevention of recurrence: A systematic review and meta-analysis of randomized controlled trials
INTRODUCTION: The recurrence rate of common bile duct stones (CBDS) after removal has been reported to exceed 10% and no established pharmacologic treatment exists for the prevention of recurrent CBDS. Many studies indicated ursodeoxycholic acid (UDCA) has the potential to prevent the recurrence of...
Autores principales: | Chen, Xun, Yan, Xiao-Ru, Zhang, Li-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250542/ https://www.ncbi.nlm.nih.gov/pubmed/30407311 http://dx.doi.org/10.1097/MD.0000000000013086 |
Ejemplares similares
-
Ursodeoxycholic acid combined with percutaneous transhepatic balloon dilation for management of gallstones after elimination of common bile duct stones
por: Chang, Hai-Yang, et al.
Publicado: (2018) -
Adding ursodeoxycholic acid to the endoscopic treatment and common bile duct stenting
for large and multiple biliary stones: Will it improve the outcomes?
por: Hormati, Ahmad, et al.
Publicado: (2020) -
Alterations of the Bile Microbiome in Recurrent Common Bile Duct Stone
por: Ye, Cheng, et al.
Publicado: (2020) -
New common bile duct morphological subtypes: Risk predictors of common bile duct stone recurrence
por: Ji, Xu, et al.
Publicado: (2022) -
Percutaneous Approach for Removal of Difficult Common Bile Duct Stones
por: Ryu, Ji Kon
Publicado: (2013)